GradedCalls Analysts
Loading the ledger…
Public news sources, graded against Yahoo Finance adjusted closes (adjusted for splits and dividends) through 16 Oct 2026. Not investment advice.
GradedCallsGradedCallsGradedCalls Analysts
Loading the ledger…
Analyst scorecard
Overall factor · 2W
29.7/100Average of active call grades
GC score3/10GC 1→GC 10
GC 1–4. Under 40 is WEAK on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
3
In this factor
Superseded
0
Visible, not scored
Hit rate
33%
Active calls only
If followed
-0.8%
Active directional calls
These calls count toward the overall factor once the horizon has a price. An open window is listed and is not in the average yet.
| Date | Ticker | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | ABBVAbbVie | Target raise Desk rating stays Neutral | Hold | — | — | |||
| Sep 2, 2026 |
| JNJJohnson & Johnson |
| Target raise Desk rating stays Buy |
| Buy |
| $267.28 |
| -2.9% |
| Miss |
| Jul 13, 2026 | LLYEli Lilly | Target raise Desk rating stays Buy | Buy | $1,195.82 | +1.3% | Hit |
| Apr 13, 2026 | PFEPfizer | Target raise Desk rating stays Neutral | Hold | $25.90 | -2.0% | Miss |
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
No superseded calls in this cut.